A team led by Tokyo Medical University researchers have identified a microRNA that regulates extracellular vesicle (EV) secretion from prostate cancer cells, offering a potential new therapeutic target for the disease. Given the role of aberrant miRNA expression in cancer and the importance of EVs to cancer progression, the scientists screened thousands of miRNAs using ExoScreen, a liquid biopsy technique they previously developed for detecting disease-specific EVs.